BenQ Medical Technology Corp.(TW:4116)
NT$40.70-0.25 (-0.61%)
TW:4116
BenQ Medical Technology Corp. financials statements
NT$40.70
At close:-0.25 (-0.61%)
BenQ Medical Technology Corp. (4116) Financial Statements
BenQ Medical Technology Corp. Financial Overview
BenQ Medical Technology Corp.'s market cap is currently NT$1.82B. The company's EPS TTM is NT$2.63; its P/E ratio is 2.38; and it has a dividend yield of 4.91%. BenQ Medical Technology Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 5.25B | NT$ 4.77B | NT$ 4.54B | NT$ 2.95B | NT$ 1.46B |
| Gross Profit | NT$ 1.69B | NT$ 1.45B | NT$ 1.34B | NT$ 860.25M | NT$ 512.28M |
| Operating Income | NT$ 342.42M | NT$ 333.39M | NT$ 365.44M | NT$ 179.12M | NT$ 49.06M |
| EBITDA | NT$ 611.55M | NT$ 618.82M | NT$ 624.71M | NT$ 476.65M | NT$ 166.74M |
| Net Income | NT$ 78.17M | NT$ 104.83M | NT$ 114.58M | NT$ 180.24M | NT$ 28.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 1.24B | NT$ 1.19B | NT$ 1.15B | NT$ 839.46M | NT$ 421.27M |
| Total Assets | NT$ 5.45B | NT$ 5.27B | NT$ 4.71B | NT$ 3.40B | NT$ 1.96B |
| Total Debt | NT$ 1.99B | NT$ 1.91B | NT$ 1.57B | NT$ 852.11M | NT$ 491.75M |
| Net Debt | NT$ 1.04B | NT$ 1.04B | NT$ 741.32M | NT$ 204.84M | NT$ 121.90M |
| Total Liabilities | NT$ 3.12B | NT$ 2.97B | NT$ 2.53B | NT$ 1.66B | NT$ 855.51M |
| Stockholders' Equity | NT$ 1.13B | NT$ 1.12B | NT$ 1.10B | NT$ 1.20B | NT$ 1.04B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 259.51M | NT$ 46.74M | NT$ 308.88M | NT$ 318.72M | NT$ 91.09M |
| Operating Cash Flow | NT$ 358.75M | NT$ 222.22M | NT$ 442.35M | NT$ 378.77M | NT$ 121.35M |
| Investing Cash Flow | NT$ -79.76M | NT$ -133.22M | NT$ -278.98M | NT$ -103.99M | NT$ -98.77M |
| Financing Cash Flow | NT$ -191.20M | NT$ -61.38M | NT$ -312.56M | NT$ 2.43M | NT$ 92.15M |
Currency in TWD

